CapsoVision to Participate in Upcoming Investor Conferences

CapsoVision’s leadership will engage with investors through presentations and 1x1 meetings at two New York conferences in September 2026.

Rhea-AI Summary

CapsoVision (CV) will participate in two upcoming investor conferences in September 2026, featuring its executive leadership team.

The company will present at the H.C. Wainwright 28th Annual Global Investment Conference, with an on-demand presentation available starting Friday, September 11, 2026 at 7:00 a.m. ET, and 1x1 investor meetings on Monday, September 14, 2026 in New York City. CapsoVision will also attend the 5th Annual ROTH Healthcare Opportunities Conference on Tuesday, September 29, 2026, conducting 1x1 investor meetings.

The on-demand presentation will be accessible on the Events page in the investor relations section of CapsoVision’s website for 90 days. Investors interested in arranging one-on-one meetings are directed to contact their H.C. Wainwright or Roth representatives, or email the company at Investors@CapsoVision.com.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SARATOGA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, plan to participate in the following upcoming investor conferences:

H.C. Wainwright 28th Annual Global Investment Conference (September 14-16 in New York City)

• Format: On-demand Company Presentation and 1x1 Investor Meetings
• Date/Time:
  • On-demand Company Presentation – Friday, September 11, 2026, beginning at 7:00 am ET
  • 1x1 Investor Meetings – Monday, September 14, 2026
    
    

5th Annual ROTH Healthcare Opportunities Conference (September 29 in New York City)

• Format: 1x1 Investor Meetings
• Date/Time: Tuesday, September 29, 2026
  
  

The on-demand presentation will be available on the Events page in the investor relations section of the company’s website for 90 days. If you are interested in arranging a one-on-one meeting with CapsoVision’s management team at the conferences, please contact your respective H.C. Wainwright and Roth representatives or reach out to the company directly at Investors@CapsoVision.com.

About CapsoVision

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com.

Investor Relations Contact
Leigh Salvo
New Street Investor Relations
Investors@CapsoVision.com

Media Contact
Leslie Strickler and Paul Spicer
Être Communications
leslies@etrecommunications.com | (804) 240-0807
pauls@etrecommunications.com | (804) 503-9231

FAQ

When will CapsoVision (CV) present at the H.C. Wainwright Global Investment Conference?

CapsoVision’s on-demand company presentation for the H.C. Wainwright 28th Annual Global Investment Conference will be available starting Friday, September 11, 2026 at 7:00 a.m. ET. The conference itself runs from September 14-16, 2026 in New York City.

What investor meetings is CapsoVision (CV) holding at the H.C. Wainwright conference?

CapsoVision plans to hold 1x1 investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026 in New York City, alongside its on-demand company presentation.

Which executives from CapsoVision (CV) will attend the upcoming investor conferences?

The participants are Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales. They plan to join both the H.C. Wainwright and ROTH investor conferences.

When is CapsoVision (CV) attending the 5th Annual ROTH Healthcare Opportunities Conference?

CapsoVision plans to participate in the 5th Annual ROTH Healthcare Opportunities Conference on Tuesday, September 29, 2026 in New York City, where the company will conduct 1x1 investor meetings with institutional investors.

How can investors access CapsoVision’s on-demand presentation and for how long?

The on-demand company presentation will be available on the Events page in the investor relations section of CapsoVision’s website for 90 days, allowing investors extended time to view the update around the September 2026 conferences.

How can investors arrange one-on-one meetings with CapsoVision (CV) at these conferences?

Investors interested in scheduling 1x1 meetings with CapsoVision’s management at the H.C. Wainwright or ROTH conferences should contact their respective H.C. Wainwright or Roth representatives, or email the company directly at Investors@CapsoVision.com.